Quadreum Solution's comment on KANGER. All Comments

Quadreum Solution
Like · Reply
The Board of Directors of Kanger is pleased to announce that National Institutes of Biotechnology Malaysia (“NIBM”), an agency under the Ministry of Science, Technology and Innovation Malaysia has issued a letter which states that NIBM has no objections for Kanger to communicate with the relevant stakeholders at Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia.   

No objection = deal ke?
Show more
x3sphere
Deal still on but need to get approval from MOH and relevant authorities first. But price not gonna rocket soon as private placement still in play. Operators gonna block the price from going up
Like · 3 years · translate